![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
David Mannino, James Siddall, Mark Small, Adam Haq, Marjorie Stiegler & Michael Bogart. (2022) Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 749-761.
Read now
Read now
Theresa M. Lee, Karen Tu, Noah M. Ivers, Jan Barnsley & Andrea S. Gershon. (2022) Measuring chronic obstructive pulmonary disease (COPD) quality indicators using primary care electronic medical records (EMRs) in Ontario, Canada. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 6:3, pages 169-183.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Osman Savran, Nina Skavlan Godtfredsen, Torben Sørensen, Christian Jensen & Charlotte Suppli Ulrik. (2020) Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 931-937.
Read now
Read now
Gary T Ferguson, Asif Shaikh, Kay Tetzlaff, Achim Mueller, Helgo Magnussen & Henrik Watz. (2020) Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2879-2888.
Read now
Read now
Mecit Suerdem, Hakan Gunen, Levent Akyildiz, Aykut Cilli, Tevfik Ozlu, Esra Uzaslan, Oznur Abadoglu, Hasan Bayram, Arif Hikmet Cimrin, Bilun Gemicioglu & Zeynep Misirligil. (2020) Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 261-267.
Read now
Read now
Jørgen Vestbo, Claus F Vogelmeier, Mark Small, James Siddall, Robert Fogel & Konstantinos Kostikas. (2019) Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 853-861.
Read now
Read now
Judith J Stephenson, Debra Wertz, Tao Gu, Jeetvan Patel & Anand A Dalal. (2017) Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1947-1959.
Read now
Read now
Sarah H. Landis, Keele Wurst, Hoa Van Le, Kerina Bonar & Yogesh S. Punekar. (2017) Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:1, pages 80-85.
Read now
Read now
Guy Brusselle, David Price, Kevin Gruffydd-Jones, Marc Miravitlles, Dorothy L Keininger, Rebecca Stewart, Michael Baldwin & Rupert C Jones. (2015) The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2207-2217.
Read now
Read now
Hakan Gunen, Mehmet Yilmaz, Oguz Aktas, Pinar Ergun, Mediha Gonenc Ortakoylu, Atike Demir, Pelin Cetinkaya, Alev Gurgun, Muge Otlu, Aykut Cilli, Ufuk Yilmaz, Nurdan Kokturk, Ipek Candemir, Halil Ibrahim Yakar, Idilhan Ar & Aylin Konya. (2015) Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2485-2494.
Read now
Read now
Elif Sen, Salih Zeki Guclu, Isil Kibar, Ulku Ocal, Veysel Yilmaz, Onur Celik, Filiz Cimen, Fusun Topcu, Meltem Orhun, Hikmet Tereci, Aylin Konya, Idilhan Ar & Sevgi Saryal. (2015) Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2657-2663.
Read now
Read now
Chee H Loh, James F Donohue & Jill A Ohar. (2015) Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary disease. Expert Opinion on Drug Safety 14:3, pages 463-472.
Read now
Read now
David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart & Katsiaryna Bichel. (2014) Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 889-905.
Read now
Read now
Keele E. Wurst, Amit Shukla, Hana Muellerova & Kourtney J. Davis. (2014) Respiratory Pharmacotherapy Use in Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in the UK: A Retrospective Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:5, pages 521-530.
Read now
Read now
Vamsi Bollu, Frank R Ernst, John Karafilidis, Krithika Rajagopalan, Scott B Robinson & Sidney S Braman. (2013) Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 631-639.
Read now
Read now
Shannon Cope, Matthias Kraemer, Jie Zhang, Gorana Capkun-Niggli & Jeroen P Jansen. (2012) Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 415-420.
Read now
Read now
Articles from other publishers (31)
Yoo-Ri Jang & Mi-Aie Lee. (2022) A study of relationships among tuberculosis knowledge, family support, and medication adherence in tuberculosis patients. The Journal of Korean Academic Society of Nursing Education 28:1, pages 80-90.
Crossref
Crossref
Andrea S. Gershon, Priscila Pequeno, Amanda Alberga Machado, Shawn D. Aaron, Tetyana Kendzerska, Jin Luo, Matthew B. Stanbrook, Wan C. Tan, Joan Porter & Teresa To. (2021) Factors Associated With Nonreceipt of Recommended COPD Medications. Chest 160:5, pages 1670-1680.
Crossref
Crossref
Svetlana I. Ovcharenko & Andrey S. Belevskiy. (2021) Benefit/risk ratio profile of single inhaler triple therapy for сhronic obstructive pulmonary disease patients. PULMONOLOGIYA 31:5, pages 645-652.
Crossref
Crossref
Manoj J. Mammen, Vandana Pai, Shawn D. Aaron, Linda Nici, Waleed Alhazzani & Paul E. Alexander. (2020) Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline. Annals of the American Thoracic Society 17:9, pages 1133-1143.
Crossref
Crossref
Nikhil Gupta, Abhijeet Singh & Rajendra Prasad. (2022) Theophylline and Leukotriene Modifiers: Is There Any Compelling Role in COPD?. Indian Journal of Respiratory Care 9:2, pages 153-161.
Crossref
Crossref
Hasan Ahmad Hasan Albitar & Vivek N. Iyer. (2020) Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world. Current Opinion in Pulmonary Medicine 26:2, pages 149-154.
Crossref
Crossref
Swetha R Palli, Ami R Buikema, Mary DuCharme, Monica Frazer, Shuchita Kaila & Timothy Juday. (2019) Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 8:15, pages 1299-1316.
Crossref
Crossref
Allison Keshishian, Lin Xie, Carole Dembek & Huseyin Yuce. (2019) Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics 41:11, pages 2283-2296.
Crossref
Crossref
Samatha Sonnappa, Richard Martin, Elliot Israel, Dirkje Postma, Wim van Aalderen, Annie Burden, Omar S. Usmani & David B. Price. (2017) Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids. PLOS ONE 12:6, pages e0178112.
Crossref
Crossref
G. Jébrak, P.-R. Burgel, D. Caillaud, G. Deslée, G. Brinchault, P. Chanez, I. Court-Fortune, R. Escamilla, P. Nesme-Meyer, C. Pinet, T. Perez, J.-L. Paillasseur & N. Roche. (2017) Évolution des traitements de fond entre 2001 et 2012 chez les patients atteints de BPCO en France. Impact de la mise à disposition des anticholinergiques de longue durée d’action. Revue des Maladies Respiratoires 34:5, pages 535-543.
Crossref
Crossref
Vamsi Bollu, Annie Guérin, Geneviève Gauthier, Robert Hiscock & Eric Q. Wu. (2016) Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists. Drugs - Real World Outcomes 4:1, pages 33-41.
Crossref
Crossref
David Price, Marc Miravitlles, Ian Pavord, Mike Thomas, Jadwiga Wedzicha, John Haughney, Katsiaryna Bichel & Daniel West. (2016) First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Barbara P Yawn, Samy Suissa & Andrea Rossi. (2016) Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Seyed Masoom Masoompour, Abbas Mohammadi & Hamideh Mahdaviazad. (2016) Adherence to the Global Initiative for Chronic Obstructive Lung Disease guidelines for management of COPD: a hospital-base study. The Clinical Respiratory Journal 10:3, pages 298-302.
Crossref
Crossref
Daniel Livorsi, Amber R. Comer, Marianne S. Matthias, Eli N. Perencevich & Matthew J. Bair. (2015) Barriers to guideline‐concordant antibiotic use among inpatient physicians: A case vignette qualitative study. Journal of Hospital Medicine 11:3, pages 174-180.
Crossref
Crossref
Yogesh Suresh Punekar, Sarah H Landis, Keele Wurst & Hoa Le. (2015) Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care. Respiratory Research 16:1.
Crossref
Crossref
Truls S. Ingebrigtsen, Jacob L. Marott, Peter Lange, Jesper Hallas, Børge G. Nordestgaard & Jørgen Vestbo. (2015) Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition. Respiratory Medicine 109:12, pages 1562-1568.
Crossref
Crossref
Nicolas Roche, Gilles Jebrak, Denis Caillaud, Gaetan Deslée, Graziella Brinchault, Pascal Chanez, Isabelle Court-Fortune, Roger Escamilla, Pascale Nesme-Meyer, Christophe Pinet, Philippe Carré, Jean-Louis Paillasseur, Thierry Perez & Pierre-Régis Burgel. (2015) Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment. European Respiratory Journal 45:1, pages 260-262.
Crossref
Crossref
Truls S. Ingebrigtsen, Jacob L. Marott, Børge G. Nordestgaard, Peter Lange, Jesper Hallas, Morten Dahl & Jørgen Vestbo. (2014) Low Use and Adherence to Maintenance Medication in Chronic Obstructive Pulmonary Disease in the General Population. Journal of General Internal Medicine 30:1, pages 51-59.
Crossref
Crossref
Nicolas Roche, Céline Pribil, Eric Van Ganse, Philippe Serrier, Bruno Housset, Déborah Poirier, Nathalie Texier, Stéphane Schück & Isabelle Boucot. (2014) Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Kyungsoo Chung, Kyungjoo Kim, Jiye Jung, Kyungwon Oh, Yeonmok Oh, Sekyu Kim, Jinhee Kim & Youngsam Kim. (2014) Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Tomoko Ishizu. (2014) Chronic obstructive pulmonary disease: Pathophysiological impact on heart failure in real clinical situation. Journal of Cardiology 64:4, pages 250-252.
Crossref
Crossref
Jørgen Vestbo, Claus Vogelmeier, Mark Small & Victoria Higgins. (2014) Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Respiratory Medicine 108:5, pages 729-736.
Crossref
Crossref
Maria Papala, Nora Kerenidi & Konstantinos I Gourgoulianis. (2013) Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD. Primary Care Respiratory Journal 22:3, pages 362-364.
Crossref
Crossref
Alyson J. McGregor, Marna Greenberg, Basmah Safdar, Todd Seigel, Robert Hendrickson, Stacey Poznanski, Moira Davenport, James Miner & Esther K. Choo. (2013) Focusing a Gender Lens on Emergency Medicine Research: 2012 Update. Academic Emergency Medicine 20:3, pages 313-320.
Crossref
Crossref
Laurent Laforest, Idlir Licaj, Gilles Devouassoux, Susanne Hartwig, Serge Marvalin & Eric Van Ganse. (2012) Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease. Chronic Respiratory Disease 10:1, pages 11-18.
Crossref
Crossref
Marc Decramer, Ronald Dahl, Oliver Kornmann, Stephanie Korn, David Lawrence & Danny McBryan. (2013) Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use. Respiratory Medicine 107:2, pages 223-232.
Crossref
Crossref
Nicolas Roche, Christos Chouaid, Bertrand Delclaux, Yan Martinat, Jean-Michel Marcos, Hervé Pégliasco & Bruno Scherrer. (2012) Multidimensional analyses to assess the relations between treatment choices by physicians and patients’ characteristics: the example of COPD. BMC Pulmonary Medicine 12:1.
Crossref
Crossref
David Price, Barbara Yawn, Guy Brusselle & Andrea Rossi. (2012) Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Primary Care Respiratory Journal 22:1, pages 92-100.
Crossref
Crossref
Min-Hee An & Ja-Yun Choi. (2012) Relationship of Knowledge, Attitude, Correct Metered Dose Inhaler Use, and Self-management Compliance among Patients with COPD. Korean Journal of Adult Nursing 24:2, pages 160-170.
Crossref
Crossref
Anand A Dalal, Manan B Shah, Anna O D’Souza, Orsolya E Lunacsek, Saurabh P Nagar & Glenn D Crater. (2012) Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD. Respiratory Research 13:1, pages 41.
Crossref
Crossref